We appreciate Hollenberg's interest in our article.1 As reported previously, participants were assigned to chlorthalidone (12.5-25 mg/d), amlodipine (2.5-10 mg/d), or lisinopril (10-40 mg/d). The distribution of doses prescribed at years 1, 3, and 5 are given in the Table. At year 1, the lowest dose was prescribed for 33.0%, 24.6% and 28.3% of the participants assigned to chlorthalidone, amlodipine, or lisinopril, respectively; the middle dose for 17.1%, 22.4%, and 15.2%; and the highest dose for 33.8%, 37.1%, and 34.3%. At year 5, the lowest dose was prescribed for 17.9%, 11.2%, and 14.0% of the participants, respectively; the middle dose for 12.9%, 13.9%, and 10.4%; and the highest dose for 40.8%, 47.6%, and 37.1%. Therefore, the majority of participants receiving lisinopril were receiving the higher dose levels of 20 mg or 40 mg during the course of the study. This pattern was consistent in participants with a baseline glomerular filtration rate less than 60 mL/min per 1.73 m2.
Thank you for submitting a comment on this article. It will be reviewed by JAMA Internal Medicine editors. You will be notified when your comment has been published. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest*
Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 3
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.